1. Topiramate treatment during adolescence induces short and long-term alterations in the reproductive system of female rats.
- Author
-
Bilibio JO, Forcato S, da Silva DG, Borges LI, Frigoli GF, Franco MDCP, Fernandes GSA, Ceravolo GS, and Gerardin DCC
- Subjects
- Animals, Female, Fructose toxicity, Fructose analogs & derivatives, Organ Size drug effects, Rats, Topiramate toxicity, Rats, Wistar, Anticonvulsants toxicity, Ovary drug effects, Uterus drug effects
- Abstract
Topiramate (TPM) is an antiepileptic drug used for treating epilepsy in children, and migraine in teenagers. In this context, preclinical studies with adult female rats observed reproductive system abnormalities following treatment with TPM. Additionally, exposure to endocrine disruptors during developmental plasticity periods, such as childhood and adolescence, may influence characteristics in the adult individual. This study evaluated whether treatment with TPM during developmental periods influences the reproductive system of female rats either immediately or in adult life. Female Wistar rats were treated with TPM (41 mg/Kg/day) by oral gavage from postnatal day (PND) 16-28, or PND 28-50, which correspond to childhood and adolescence, respectively, and euthanized either 24 h after the final administration or during adulthood. Treatment with TPM during adolescence induced short-term increase in uterus and ovary weights and reduction in endometrial stroma thickness. Adult animals treated during adolescence displayed reduced primordial ovarian follicles' numbers, and increased primary and pre-antral ovarian follicles' numbers. Treatment during childhood induced no short or long-term differences. These results indicate TPM treatment during adolescence is capable of inducing short and long-term alterations on the reproductive system of female Wistar rats., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Graziela Scalianti Ceravolo reports financial support and equipment, drugs, or supplies were provided by Fundação Araucária. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF